3705 Music Branch Rd, Ashland, KY 41102 · +1 (606) 465-9063 · prymalab.net
Certificate no.
PL-26-00046
Verification key
9WNXD2PS
Scan or enter both at prymalab.net/testing/verify
Certificate of Analysis · Lot release
HCG 5,000 IU
Lot PL-2609-046 · Lyophilized powder · Label claim 5,000 IU/vial (≈ 0.5 mg glycoprotein, standardized by bioassay)
Tested in-house by PrymaLab
In-house analytical result, not an independent third-party test
Lot / batch number
PL-2609-046
Date made
2026-09-18
Date of analysis
2026-09-19
Date issued
2026-10-03
Retest / expiry
2028-09-18
Units in lot / sampled
250 / 2
Storage
2–8 °C, dark
Certificate type
Lot COA, 2 pages
Compound
HCG
Human chorionic gonadotropin (urinary); potency assigned in IU by bioassay
CAS number
9002-61-3
Molecular formula
Not applicable (glycoprotein)
Theoretical mass (avg.)
About 36–38 kDa glycoform average; 25.7 kDa protein core (about 30% carbohydrate)
Structure
Non-covalent heterodimer, 237 residues in total: common glycoprotein-hormone α-subunit (92 aa) paired with the hCG β-subunit (145 aa, including the 24-residue C-terminal peptide); 11 disulfides; N- and O-glycosylated.
Purity · RP-HPLC, area %
99.20%
Specification 99.0% • main peak (glycoform cluster) at 7.28 min
Identity · Observed Mass
36,712 Da
Deconvoluted glycoform centroid • theoretical 36.7 kDa average
Overall conclusion
PASS
Meets every specification for the tests performed
Test
Method
Specification
Result
Conclusion
Appearance
Visual inspection
White to off-white lyophilized powder or cake
White lyophilized cake
PASS
Identity (mass)
LC-MS, ESI positive
Within glycoform envelope
36,712 Da centroid (glycoforms 36–38 kDa)
PASS
Purity
RP-HPLC, UV 214 nm, area%
99.0%
99.20%
PASS
Largest impurity
RP-HPLC, area%
1.0%
0.32% at 6.58 min (free β-subunit)
PASS
Water content
Karl Fischer
5.0%
1.7%
PASS
Bacterial endotoxin
LAL, kinetic
≤ 5.0 EU/mg
0.22 EU/mg
PASS
Sterility / bioburden
USP <71>, membrane filtration
No growth after 14 days
No growth; conforms
PASS
1HPLC chromatogram
Data file: HCG_PL-2609-046_20260919_01 · Column C18, 150 × 4.6 mm · UV 214 nm
Baseline uncropped; main peak (intact heterodimer glycoform cluster) and impurities labeled with retention times. Peak table on page 2.
PrymaLab
Certificate of Analysis · continued
HCG 5,000 IU · Lot PL-2609-046 · Certificate PL-26-00046
Lot PL-2609-046
Method, peak table and approval
2HPLC method · HCG_PL-2609-046_20260919_01
Instrument
Waters Alliance e2695, SN E2695B742
Data System
Empower 3, Build 3471
Detector
Waters 2998 PDA
Detection Wavelength
214 nm
Column
C18, 150 × 4.6 mm, 3.5 µm
Column Part / Serial
186003326 / USHX18211
Mobile Phase A
0.1% TFA in water
Mobile Phase B
0.1% TFA in MeCN
Flow Rate
1.0 mL/min
Column Temperature
30 °C
Injection Volume
20 µL
Run Time
10 min
Sample Diluent
Water, 0.1% TFA
Sample Concentration
0.2 mg/mL (pooled composite)
Blank Injected
Yes
Reference Standard
In-house hCG reference, lot PL-RS-HCG-01, RT 7.26 min (glycoform cluster)
3Gradient program
Time (min)
% A
% B
0.0
95
5
3.0
95
5
7.0
55
45
8.0
20
80
9.0
20
80
10.0
95
5
4Peak table
Peak
RT (min)
Area
Area %
1 (free β-subunit)
6.58
13,760
0.32
2
7.28
4,265,600
99.20
3 (aggregates)
7.90
12,470
0.29
4 (CTP variants)
8.38
8,170
0.19
Total
4,300,000
100.00
Threshold 0.05% area · Blank subtracted: Y · Purity = main peak area ÷ total integrated area × 100, to two decimals; main peak shaded.
5Identity by mass spectrometry
Instrument
Waters Acquity SQD
Ionization / Mode
ESI, positive
Observed m/z (charge)
1836.6 (20+ [M+20H]) · 1597.2 (23+ [M+23H])
Deconvoluted Mass
36,712 Da (glycoform centroid)
Theoretical Mass
36,700 Da average glycoform (25.7 kDa protein core)
Difference
Within urinary glycoform envelope (36–38 kDa)
Data File
HCG_PL-2609-046_MS_20260919_01
Acceptance
Within glycoform envelope
6Additional tests
Test
Performed by
Date
Report / file
Water content
PrymaLab
2026-09-20
RPT-KF-PL-2609-046
Endotoxin
PrymaLab
2026-09-21
RPT-ET-PL-2609-046
Sterility
PrymaLab
2026-10-02
RPT-ST-PL-2609-046
A test with no row here was not performed on this lot. Outside-laboratory reports, when used, are attached and named below.
7Review and approval
D. Reynolds Analyst · performed the testing Date: 2026-09-19
S. Calloway Reviewer · checked against raw data Date: 2026-10-02
M. Phelps Lab Director · approved for release Date: 2026-10-03